The Future of Biotech in Drug Discovery

Biotech driven drug discovery continues to be one of the fastest growing markets globally. The advancement in technology has enabled researchers to accelerate the time to market, while continuing to optimize the costs.

Aurigene Announces the Opening of Its Biologics Facility

Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft.in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed...

Eli Lilly Funds Another USD 5.3 Billion in Indiana Unit

Eli Lilly, a pharmaceutical company, has declared it is funding one more $5.3 billion in an manufacturing plant in Lebanon, Indiana, to support the assembling of its exceptionally famous weight reduction drug Zepbound, diabetes treatment Mounjaro...

Emcure And Gennova To Resume mRNA Collaboration With HDT

Emcure Pharmaceuticals Ltd. and its biotech subsidiary, Gennova Biopharmaceuticals Ltd. have amicably resolved all legal disputes with HDT Bio Corp. The litigation between them, including before US courts and the arbitral tribunal in London, has...

Glenmark amplifies Nationwide Heart Health Initiative with the Next Phase of India First Heart First Campaign

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceuticals company, proudly announced the launch of the next phase of ‘India First Heart First’ campaign.

The Role of Tech and AI in Drug Discovery Today

The biggest challenge in drug discovery today is the time taken. The number of new drugs entering the market compared to the number of drugs required is very less. Moreover, for the phase 2 clinical trials, the failure rate is over 90% percent which

The Usage of Medical Cannabis in the Nutraceutical Industry

Medical cannabis is gaining recognition for its multifaceted medicinal advantages. Individuals grappling with anxiety, stress disorders, insomnia, depression, and chronic pain management have found solace in cannabis medicines

Pharma Giant Sanofi To Fund over 1 Billion Euro in French Production Sites

Sanofi, a leading pharmaceutical and healthcare firm, reports a venture of more than €1 billion to establish a new bioproduction limit at its locales in Vitry-sur-Seine (Val de Marne), Le Quality (Seine-Oceanic) and Lyon Gerland (Rhône)...

Strides receives USFDA approval for Sevelamer Carbonate Tablets, 800 mg

Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Sevelamer Carbonate Tablets, 800 mg, from the USFDA

Automation Technologies Revolutionizing Pharmaceutical Supply Chain Management

Warehouse automation companies are pivotal in assisting E-pharma companies in India to elevate their profitability and efficiency through innovative automation solutions